Affinity Asset Advisors, LLC Q1 2025 Filing
Filed May 14, 2025
Portfolio Value
$1.0T
Holdings
91
Report Date
Q1 2025
Filing Type
13F-HR
All Holdings (91 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SPYSPDR S&P 500 ETF TR | 430,000 | $240.5B | 22.96% | Put |
| 2 | IWMISHARES TR | 300,000 | $59.8B | 5.71% | Put |
| 3 | XENEXENON PHARMACEUTICALS INC | 1,328,175 | $44.6B | 4.25% | |
| 4 | APGEAPOGEE THERAPEUTICS INC | 1,151,199 | $43.0B | 4.10% | |
| 5 | XBISPDR SERIES TRUST | 500,000 | $40.5B | 3.87% | Put |
| 6 | VRNAVERONA PHARMA PLC | 615,000 | $39.0B | 3.73% | |
| 7 | ACLXARCELLX INC | 530,000 | $34.8B | 3.32% | |
| 8 | ALKSALKERMES PLC | 1,000,000 | $33.0B | 3.15% | |
| 9 | NUVLNUVALENT INC | 460,000 | $32.6B | 3.11% | |
| 10 | PTGXPROTAGONIST THERAPEUTICS INC | 572,500 | $27.7B | 2.64% | Call |
| 11 | MDGLMADRIGAL PHARMACEUTICALS INC | 80,000 | $26.5B | 2.53% | |
| 12 | CNTACENTESSA PHARMACEUTICALS PLC | 1,546,662 | $22.2B | 2.12% | |
| 13 | AMGNAMGEN INC | 70,000 | $21.8B | 2.08% | Call |
| 14 | TEVATEVA PHARMACEUTICAL INDS LTD | 1,400,000 | $21.5B | 2.05% | |
| 15 | MLYSMINERALYS THERAPEUTICS INC | 1,300,000 | $20.6B | 1.97% | Put |
| 16 | TVTXTRAVERE THERAPEUTICS INC | 1,070,000 | $19.2B | 1.83% | |
| 17 | VERAVERA THERAPEUTICS INC | 620,143 | $14.9B | 1.42% | Call |
| 18 | ALNYALNYLAM PHARMACEUTICALS INC | 55,000 | $14.9B | 1.42% | Call |
| 19 | WVEWAVE LIFE SCIENCES LTD | 1,825,000 | $14.7B | 1.41% | |
| 20 | OMER 5.25 02/15/26OMEROS CORP | 15,525,000 | $14.3B | 1.36% | |
| 21 | MRUSMERUS N V | 321,962 | $13.6B | 1.29% | |
| 22 | AXSMAXSOME THERAPEUTICS INC | 100,000 | $11.7B | 1.11% | |
| 23 | KPTI 3 10/15/25KARYOPHARM THERAPEUTICS INC | 15,250,000 | $11.6B | 1.11% | |
| 24 | ESTAESTABLISHMENT LABS HLDGS INC | 280,000 | $11.4B | 1.09% | |
| 25 | IM8NINSMED INC | 140,000 | $10.7B | 1.02% | |
| 26 | BBIOBRIDGEBIO PHARMA INC | 300,000 | $10.4B | 0.99% | |
| 27 | NAMSNEWAMSTERDAM PHARMA COMPANY | 499,800 | $10.2B | 0.98% | Put |
| 28 | NRIXNURIX THERAPEUTICS INC | 810,669 | $9.6B | 0.92% | |
| 29 | HTDCORCEPT THERAPEUTICS INC | 70,000 | $8.0B | 0.76% | Call |
| 30 | TRVITREVI THERAPEUTICS INC | 1,250,000 | $7.9B | 0.75% | |
| 31 | SYRESPYRE THERAPEUTICS INC | 481,678 | $7.8B | 0.74% | |
| 32 | IMVTIMMUNOVANT INC | 430,000 | $7.3B | 0.70% | |
| 33 | TVTX 2.25 03/01/29TRAVERE THERAPEUTICS INC | 7,000,000 | $7.0B | 0.67% | |
| 34 | ORKAORUKA THERAPEUTICS INC | 545,362 | $5.6B | 0.53% | |
| 35 | NBIXNEUROCRINE BIOSCIENCES INC | 50,000 | $5.5B | 0.53% | |
| 36 | AVTXAVALO THERAPEUTICS INC | 657,154 | $5.3B | 0.50% | |
| 37 | VRDNVIRIDIAN THERAPEUTICS INC | 390,000 | $5.3B | 0.50% | |
| 38 | LXEOLEXEO THERAPEUTICS INC | 1,480,881 | $5.1B | 0.49% | |
| 39 | CRNXCRINETICS PHARMACEUTICALS IN | 152,252 | $5.1B | 0.49% | |
| 40 | EX9EXELIXIS INC | 135,000 | $5.0B | 0.48% | Call |
| 41 | RZLTREZOLUTE INC | 1,700,000 | $4.9B | 0.47% | |
| 42 | CATXPERSPECTIVE THERAPEUTICS INC | 2,224,196 | $4.7B | 0.45% | |
| 43 | AUTLAUTOLUS THERAPEUTICS PLC | 3,045,000 | $4.7B | 0.45% | |
| 44 | ERASERASCA INC | 3,341,519 | $4.6B | 0.44% | |
| 45 | EWTXEDGEWISE THERAPEUTICS INC | 200,000 | $4.4B | 0.42% | Put |
| 46 | PRQRPROQR THRAPEUTICS N V | 3,284,512 | $4.4B | 0.42% | |
| 47 | QUREUNIQURE NV | 400,000 | $4.2B | 0.40% | |
| 48 | —PERCEPTIVE CAP SOLUTIONS COR | 350,000 | $3.6B | 0.35% | |
| 49 | SLNOSOLENO THERAPEUTICS INC | 50,000 | $3.6B | 0.34% | |
| 50 | INZYINOZYME PHARMA INC | 3,867,710 | $3.5B | 0.34% | |
| 51 | IBRXIMMUNITYBIO INC | 1,025,000 | $3.1B | 0.29% | Put |
| 52 | AKBAAKEBIA THERAPEUTICS INC | 1,500,000 | $2.9B | 0.27% | |
| 53 | CMPXCOMPASS THERAPEUTICS INC | 1,461,507 | $2.8B | 0.27% | Put |
| 54 | MAZEMAZE THERAPEUTICS INC | 250,000 | $2.8B | 0.26% | |
| 55 | NAMSNEWAMSTERDAM PHARMA COMPANY | 241,957 | $2.7B | 0.26% | |
| 56 | KYMRKYMERA THERAPEUTICS INC | 100,000 | $2.7B | 0.26% | |
| 57 | OACCOAKTREE ACQUISITION CORP III | 250,000 | $2.6B | 0.25% | |
| 58 | GONGERON CORP | 1,500,000 | $2.4B | 0.23% | |
| 59 | MNPRMONOPAR THERAPEUTICS INC | 62,000 | $2.3B | 0.22% | |
| 60 | PHPNGALECTIN THERAPEUTICS INC | 1,836,200 | $2.2B | 0.21% | Put |
| 61 | MIRMMIRUM PHARMACEUTICALS INC | 49,692 | $2.2B | 0.21% | |
| 62 | AVTEAEROVATE THERAPEUTICS INC | 800,000 | $2.0B | 0.19% | |
| 63 | CGEMCULLINAN THERAPEUTICS INC | 263,817 | $2.0B | 0.19% | |
| 64 | CLYMCLIMB BIO INC | 1,500,000 | $1.8B | 0.17% | |
| 65 | OKURONKURE THERAPEUTICS INC | 394,159 | $1.7B | 0.16% | |
| 66 | TRMLTOURMALINE BIO INC | 100,000 | $1.5B | 0.15% | Call |
| 67 | ROIVROIVANT SCIENCES LTD | 150,000 | $1.5B | 0.14% | |
| 68 | NKTXNKARTA INC | 800,000 | $1.5B | 0.14% | |
| 69 | AVRANTERIS TECHNOLOGIES GLOBAL | 390,000 | $1.4B | 0.14% | |
| 70 | MBXMBX BIOSCIENCES INC | 175,000 | $1.3B | 0.12% | |
| 71 | THRDTHIRD HARMONIC BIO INC | 370,000 | $1.3B | 0.12% | |
| 72 | ETNBGBP89BIO INC | 175,000 | $1.3B | 0.12% | |
| 73 | ABVXABIVAX SA | 200,000 | $1.3B | 0.12% | |
| 74 | OLMAOLEMA PHARMACEUTICALS INC | 325,000 | $1.2B | 0.12% | |
| 75 | NXTCNEXTCURE INC | 2,302,598 | $1.1B | 0.11% | |
| 76 | MGTXMEIRAGTX HOLDINGS PLC | 150,000 | $1.0B | 0.10% | |
| 77 | PCVXVAXCYTE INC | 25,000 | $944.0M | 0.09% | |
| 78 | VKTXVIKING THERAPEUTICS INC | 25,000 | $603.8M | 0.06% | |
| 79 | STROSUTRO BIOPHARMA INC | 752,722 | $489.7M | 0.05% | |
| 80 | CNTXCONTEXT THERAPEUTICS INC | 660,589 | $404.3M | 0.04% | |
| 81 | BDTXBLACK DIAMOND THERAPEUTICS I | 250,000 | $387.5M | 0.04% | |
| 82 | RADXRADIOPHARM THERANOSTICS LTD | 64,600 | $310.7M | 0.03% | |
| 83 | ZURAZURA BIO LTD | 223,335 | $288.1M | 0.03% | |
| 84 | OVIDOVID THERAPEUTICS INC | 667,516 | $208.2M | 0.02% | |
| 85 | RPTXREPARE THERAPEUTICS INC | 200,000 | $197.2M | 0.02% | |
| 86 | ADGMADAGIO MED HLDGS INC | 213,235 | $169.5M | 0.02% | |
| 87 | OMEROMEROS CORP | 9,958 | $81.9M | 0.01% | |
| 88 | ALLKGUSDALLAKOS INC | 250,000 | $56.9M | 0.01% | |
| 89 | QTTBQ32 BIO INC | 27,777 | $45.8M | 0.00% | |
| 90 | RCKTWROCKET PHARMACEUTICALS INC | 75,000 | $3.5M | 0.00% | |
| 91 | IMTXIMMATICS N.V | 187,204 | $3.0M | 0.00% |